Revolution Medicines Inc. (RVMD) News

Revolution Medicines Inc. (RVMD): $25.61

0.30 (+1.19%)

POWR Rating

Component Grades













Add RVMD to Watchlist
Sign Up

Industry: Biotech


of 373

in industry

Filter RVMD News Items

RVMD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

RVMD News Highlights

  • For RVMD, its 30 day story count is now at 9.
  • Over the past 12 days, RVMD's stories per day has been in a clear downtrend, falling by about 0.26 per 2 days.
  • The most mentioned tickers in articles about RVMD are BEAT, ACRX and PR.

Latest RVMD News From Around the Web

Below are the latest news stories about REVOLUTION MEDICINES INC that investors may wish to consider to help them evaluate RVMD as an investment opportunity.

Revolution Medicines, Inc. (NASDAQ:RVMD) Analysts Just Trimmed Their Revenue Forecasts By 25%

The latest analyst coverage could presage a bad day for Revolution Medicines, Inc. ( NASDAQ:RVMD ), with the analysts...

Yahoo | May 13, 2023

Revolution Medicines First Quarter 2023 Earnings: Beats Expectations

Revolution Medicines ( NASDAQ:RVMD ) First Quarter 2023 Results Key Financial Results Revenue: US$7.01m (down 7.4% from...

Yahoo | May 10, 2023

Q1 2023 Revolution Medicines Inc Earnings Call

Q1 2023 Revolution Medicines Inc Earnings Call

Yahoo | May 9, 2023

Revolution Medicines, Inc. (RVMD) Reports Q1 Loss, Tops Revenue Estimates

Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of 14.29% and 68.36%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 8, 2023

Revolution Medicines Reports First Quarter 2023 Financial Results and Update on Corporate Progress

First Wave of Investigational RAS(ON) Inhibitors – RMC-6236 (RASMULTI), RMC-6291 (KRASG12C) and RMC-9805 (KRASG12D) – progressing on plan Appointment of chief medical officer and key leaders across late-stage development and commercial planning $909.8 million in cash, cash equivalents and investments at the end of first quarter 2023 Conference call and webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clini

Yahoo | May 8, 2023

AcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

AcelRx Pharmaceuticals (ACRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | May 3, 2023

Wall Street Analysts Think Revolution Medicines, Inc. (RVMD) Could Surge 27.24%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 27.2% in Revolution Medicines, Inc. (RVMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | May 3, 2023

Revolution Medicines to Report Financial Results for First Quarter 2023 After Market Close on May 8, 2023

REDWOOD CITY, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers, today announced that it will report financial results for the first quarter 2023 on Monday, May 8, 2023, after market close. At 4:30 p.m. Eastern Time that day (1:30 p.m. Pacific Time), Revolution Medicines’ senior management team will host a webcast to discuss the financial results for the quarter and pr

Yahoo | May 1, 2023

Revolution Medicines, Inc. (RVMD) Expected to Beat Earnings Estimates: Should You Buy?

Revolution Medicines, Inc. (RVMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | May 1, 2023

Revolution Medicines, Inc.'s (NASDAQ:RVMD) one-year returns climbed after last week's 16% gain, institutional investors must be happy

Key Insights Significantly high institutional ownership implies Revolution Medicines' stock price is sensitive to their...

Yahoo | April 19, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5808 seconds.